Hervé Gisserot

Hervé Gisserot was appointed Executive Vice President, Business Development & Enterprise Alliance Management, in December 2025 and is a member of CSL’s Global Leadership Group.

In this role, Hervé leads the Business Development & Enterprise Alliance Management team. In collaboration with R&D and Commercial colleagues, Hervé is responsible for executing CSL’s Portfolio Development & Commercialization strategy by sourcing external innovation, expanding our clinical and commercial portfolio and enhancing the value of our strategic partnerships.

Hervé joined CSL in 2022 as General Manager of CSL Vifor, where he was responsible for the global CSL Vifor Business Unit including leading a team of approx. 2,000 professionals focusing on the strategic therapy areas of iron replacement and nephrology and ultimately integrating this with CSL.

With more than 30 years of extensive commercial experience in the healthcare sector across the U.S., Europe, China, and Japan, Hervé has served in progressive senior leadership roles at GlaxoSmithKline, Sanofi-Aventis, and Fournier Group.

Hervé is a graduate of the Institute of Political Science Paris (IEP) and has completed the General Management program at INSEAD.

In addition to his current responsibilities, in June 2022, Hervé was nominated to the Strategic Committee of Brenus Pharma, a France-based Oncology start-up company.